| Primary |
| Alpha-1 Anti-trypsin Deficiency |
77.6% |
| Chronic Obstructive Pulmonary Disease |
6.1% |
| Emphysema |
4.8% |
| Obstructive Airways Disorder |
4.2% |
| Alpha-1 Anti-trypsin |
2.4% |
| Pruritus |
1.2% |
| Alpha-1 Anti-trypsin Decreased |
0.6% |
| Alpha-1 Anti-trypsin Increased |
0.6% |
| Asthma |
0.6% |
| Bronchitis Chronic |
0.6% |
| Enzyme Abnormality |
0.6% |
| Nausea |
0.6% |
|
| Pneumonia |
20.9% |
| Death |
7.0% |
| Respiratory Failure |
5.8% |
| Respiratory Tract Infection |
5.8% |
| Cataract |
4.7% |
| Lower Respiratory Tract Infection |
4.7% |
| Lung Disorder |
4.7% |
| Rash |
4.7% |
| Upper Respiratory Tract Infection |
4.7% |
| Vomiting |
4.7% |
| Chronic Obstructive Pulmonary Disease |
3.5% |
| Fall |
3.5% |
| Headache |
3.5% |
| Hospitalisation |
3.5% |
| Infusion Related Reaction |
3.5% |
| Kidney Infection |
3.5% |
| Lung Infection |
3.5% |
| Wrong Technique In Drug Usage Process |
3.5% |
| Abortion Spontaneous |
2.3% |
| Chest Discomfort |
2.3% |
|
| Secondary |
| Alpha-1 Anti-trypsin Deficiency |
76.8% |
| Chronic Obstructive Pulmonary Disease |
14.4% |
| Emphysema |
6.4% |
| Obstructive Airways Disorder |
1.6% |
| Asthma |
0.8% |
|
| Respiratory Tract Infection |
10.0% |
| Upper Respiratory Tract Infection |
10.0% |
| Nasal Congestion |
8.3% |
| Hypoaesthesia |
6.7% |
| Lower Respiratory Tract Infection |
6.7% |
| Nausea |
6.7% |
| Pneumonia |
6.7% |
| Fatigue |
5.0% |
| Headache |
5.0% |
| Viral Upper Respiratory Tract Infection |
5.0% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Epstein-barr Virus Test Positive |
3.3% |
| Fall |
3.3% |
| Feeling Abnormal |
3.3% |
| Infusion Related Reaction |
3.3% |
| Sinusitis |
3.3% |
| Sleep Disorder |
3.3% |
| Wound Infection |
3.3% |
| Arterial Bypass Operation |
1.7% |
| Asthenia |
1.7% |
|
| Concomitant |
| Alpha-1 Anti-trypsin Deficiency |
35.3% |
| Chronic Obstructive Pulmonary Disease |
17.6% |
| Pulmonary Arterial Hypertension |
17.6% |
| Immunosuppression |
11.8% |
| Emphysema |
5.9% |
| Oedema |
5.9% |
| Senile Osteoporosis |
5.9% |
|
| Respiratory Failure |
20.0% |
| Chronic Obstructive Pulmonary Disease |
10.0% |
| Dyspnoea |
10.0% |
| Heart Rate Increased |
10.0% |
| Oedema Peripheral |
10.0% |
| Off Label Use |
10.0% |
| Pain In Extremity |
10.0% |
| Thrombotic Thrombocytopenic Purpura |
10.0% |
| Wheezing |
10.0% |
|
